Evidence map›Paper›PMID 26983597›Full record

ArticleScientific reports2016

Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA.

Thomas P Schmidt, Anna M Perna, Tim Fugmann, Manja Böhm, Jan Hiss, Sarah Haller, Camilla Götz, Nicole Tegtmeyer, Benjamin Hoy, Tilman T Rau and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Distinct Modulation ofBiomolecules · 2026
    Article
  3. Article
  4. Update on the pathogenesis and clinical management ofWorld journal of gastrointestinal pathophysiology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cells · 2024
    Article
  11. The immunopathogenesis ofFrontiers in microbiology · 2024
    Review
  12. Investigating the role of aFrontiers in oral health · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development.Current topics in microbiology and immunology · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Thomas P SchmidtCancer Cluster Salzburg, Department of Molecular Biology, University of Salzburg, Austria.
Anna M PernaDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Tim FugmannPhilochem AG, Otelfingen, Switzerland.
Manja BöhmDivision of Microbiology, University of Erlangen-Nuremberg, Germany.
Jan HissDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Sarah HallerDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Camilla GötzCancer Cluster Salzburg, Department of Molecular Biology, University of Salzburg, Austria.
Nicole TegtmeyerDivision of Microbiology, University of Erlangen-Nuremberg, Germany.
Benjamin HoyCancer Cluster Salzburg, Department of Molecular Biology, University of Salzburg, Austria.
Tilman T RauInstitute of Pathology, University of Erlangen-Nuremberg, Germany.
Dario NeriDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Steffen BackertDivision of Microbiology, University of Erlangen-Nuremberg, Germany.
Gisbert SchneiderDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Silja WesslerCancer Cluster Salzburg, Department of Molecular Biology, University of Salzburg, Austria.
ETH Zurich · CHFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Salzburg · ATPhilochem (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cell adhesion protein and tumour suppressor E-cadherin exhibits important functions in the prevention of gastric cancer. As a class-I carcinogen, Helicobacter pylori (H. pylori) has developed a unique strategy to interfere with E-cadherin functions. In previous studies, we have demonstrated that H. pylori secretes the protease high temperature requirement A (HtrA) which cleaves off the E-cadherin ectodomain (NTF) on epithelial cells. This opens cell-to-cell junctions, allowing bacterial transmigration across the polarised epithelium. Here, we investigated the molecular mechanism of the HtrA-E-cadherin interaction and identified E-cadherin cleavage sites for HtrA. Mass-spectrometry-based proteomics and Edman degradation revealed three signature motifs containing the [VITA]-[VITA]-x-x-D-[DN] sequence pattern, which were preferentially cleaved by HtrA. Based on these sites, we developed a substrate-derived peptide inhibitor that selectively bound and inhibited HtrA, thereby blocking transmigration of H. pylori. The discovery of HtrA-targeted signature sites might further explain why we detected a stable 90 kDa NTF fragment during H. pylori infection, but also additional E-cadherin fragments ranging from 105 kDa to 48 kDa in in vitro cleavage experiments. In conclusion, HtrA targets E-cadherin signature sites that are accessible in in vitro reactions, but might be partially masked on epithelial cells through functional homophilic E-cadherin interactions.

Indexed as

Amino Acid MotifsAntigens, CDBacterial ProteinsCadherinsCell Line, TumorChromatography, High Pressure LiquidEpithelial CellsHelicobacter pyloriHumansMolecular Sequence DataPeptidesProtein BindingProteolysisProteomicsRecombinant Fusion ProteinsSerine ProteasesAntigens, CDBacterial ProteinsCadherinsCDH1 protein, humanPeptidesRecombinant Fusion ProteinsSerine Proteases

Identifiers

PMID26983597
PMCPMC4794652
OpenAlexW2328307062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.